Market Capitalization (Millions $) |
241 |
Shares
Outstanding (Millions) |
50 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
0 |
Cash Flow (TTM) (Millions $) |
0 |
Capital Exp. (TTM) (Millions $) |
6 |
Exscientia Plc
Exscientia Plc is a leading artificial intelligence (AI)-driven drug discovery company. The company utilizes machine learning algorithms and AI approaches to design and develop new drugs, with the aim of accelerating the drug discovery process. Exscientia combines computational technologies with human expertise to discover and optimize potential drug candidates, enabling the development of new therapies for various diseases. The company partners with pharmaceutical companies and uses its advanced technology platform to help identify and prioritize drug targets, design molecules, and optimize lead compounds. Through its innovative approach, Exscientia aims to revolutionize the pharmaceutical industry by delivering safer and more effective drugs in a faster and more cost-efficient manner.
Company Address: The Schr??dinger Building Oxford 0
Company Phone Number: 1865 818941 Stock Exchange / Ticker: NASDAQ EXAI
|